This hypothesis has been supported by the findings that Mer deficiency in CD11b+ leucocytes promoted a CD8+ T lymphocyte mediated antitumor immune response and inhibited tumor growth and metastasis in the murine tumor models [42]. This evidence concerns the gene MERTK and neoplasm.